Comparison of Anesthetic Efficacy and Safety Between Nerve Block and Infiltrative Technique for Mandibular Posterior Implant Placement.

Launched by UNIVERSITY OF BARCELONA · Oct 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods of numbing the mouth during the placement of dental implants in the back of the jaw. The goal is to see which method is safer and more effective in reducing pain after the procedure. One method is called the inferior dental nerve block (IDNB), and the other is the infiltrative technique (TINF). Researchers want to find out if IDNB helps patients feel less pain during and after the surgery compared to TINF, and whether it causes more side effects.

To be eligible for this study, participants must be at least 18 years old, have missing teeth in the back of their mouth, and generally be in good health. Pregnant women, people with certain allergies, or those with uncontrolled health issues cannot participate. If you join the study, you’ll receive one of the two numbing techniques before your dental implant surgery. Your experience will be monitored by researchers who are not involved in the procedure, ensuring a fair and unbiased assessment of the results. This trial is a great opportunity for those in need of dental implants to contribute to important research while receiving care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of legal age (≥18 years), partially edentulous, requiring the placement of one or more mandibular implants in the molar area.
• • Patients without relevant systemic pathology (equal or lower than ASA II).
• • Sufficient intellectual capacity to understand the study, the informed consent and to adequately complete the questionnaires.
• Exclusion Criteria:
• • - Pregnant patients.
• • Patients with allergy or hypersensitivity to articaine or adrenaline.
• • Patients with uncontrolled systemic diseases.
• • Patients who may recognize the anesthetic technique used (e.g. dentists).
• • Drugs or systemic diseases (ASA III or higher) that contraindicate surgical intervention or the use of anesthetics and/or vasoconstrictors.
• • Patients with relative or absolute contraindication of conventional analgesic or anti-inflammatory regimen.
• • Immediate implants.
• • Surgeries requiring bone grafts.